Naloxone Education and Access Act
A BILL
To amend the Public Health Service Act with respect to opioid overdose reversal medication access, education, and co-prescribing grant programs, and for other purposes.
Sec. 2 Opioid overdose reversal medication access, education, and co-prescribing grant programs
“(3) encourage health care providers to co-prescribe, as appropriate, drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose;
“(4) support innovative community-based distribution programs of drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose;”
“(3) Limitation—An eligible entity may use—
“(A) not more than 10 percent of a grant under this section for educating the public pursuant to subsection (a)(6); and
“(B) not less than 20 percent of a grant under this section to offset cost-sharing for distribution and dispensing of drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose.”
“(g) Definitions—In this section:
“(1) Eligible entity—The term eligible entity means a State, locality, Indian Tribe, Tribal organization, or Urban Indian organization.
“(2) Indian Tribe—The term Indian Tribe has the meaning given the term in section 4 of the Indian Self-Determination and Education Assistance Act.
“(3) Standing order—The term standing order means a document prepared by a person authorized to prescribe medication that permits another person to acquire, dispense, or administer medication without a person-specific prescription.
“(4) Tribal organization—The term Tribal organization has the meaning given the term in section 4 of the Indian Self-Determination and Education Assistance Act.
“(5) Urban Indian organization—The term Urban Indian organization has the meaning given the term in section 4 of the Indian Health Care Improvement Act.”